Compare · IGAP vs MDLN
IGAP vs MDLN
Side-by-side comparison of Integrity Applications Inc. (IGAP) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IGAP and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $49.43B, about 1009.2x IGAP ($49.0M).
- MDLN has hit the wire 5 times in the past 4 weeks while IGAP has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for IGAP).
- Company
- Integrity Applications Inc.
- Medline Inc.
- Price
- $3.15-9.74%
- $37.65+1.24%
- Market cap
- $49.0M
- $49.43B
- 1M return
- -
- +6.55%
- 1Y return
- -
- -7.62%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 0
- 5
- Recent ratings
- 0
- 25
Integrity Applications Inc.
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Latest IGAP
- GlucoTrack, Inc. Announces Effectiveness Of Corporate Name Change And Ticker Symbol Change
- GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 51 Biggest Movers From Yesterday
- Integrity Applications Issues Shareholder Update Letter
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)